.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progression f...
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the su...
Cardiovascular diseases (CVDs) present a substantial global health concern, and Malaysia, is not immune to this health issue. As reported by the World Heal...
Thailand Hub of Talents in Cancer Immunotherapy (TTCI), funded by the National Research Council of Thailand (NRCT), has been recently launched by ...
Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based gl...
“LifeSci Partners is the leading provider of healthcare advisory services, with a strong presence in the U.S., Europe and Israel. We now have a great...
US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...
Enzene Biosciences, a subsidiary of Mumbai-India, based Alkem Laboratories, has announced the inauguration of its cutting-edge research and...
To launch the initiative Mandira Bedi, an actress, television presenter and a health & fitness icon, joined Zimmer Biomet Asia Pacific Group President ...
“We are building a new ecosystem in global public health,” said Anuradha Gupta, President of Global Immunization at Sabin. “We aim to cre...
ImmunoGen to Receive $34 Million1 in Upfront and Near-Term Milestone Payments and is Eligible to Receive Potential Regulatory and Commercial Milestone Paym...
Uro-G offers a viewing angle of 120°, both 210° upward and 130° downward motion angles, and a 90° angle of rotation clockwise and countercl...
Event co-organizer the Taiwan Bio Industry Organization (Taiwan BIO), stated that international participation was notably higher this year due to the lifti...
Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) announced that the two companies have entered into a lo...
© 2025 Biopharma Boardroom. All Rights Reserved.
